Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-15
    E.g., 2018-10-15

Archive Search

1 results
1:12 PM, Sep 22, 2017  |  BC Week In Review | Financial News  |  Completed Offerings

AbClon raises W6.8B in IPO

is in preclinical testing to treat gastric and breast cancer. In 2016, AbClon granted Shanghai Henlius
Inc. (Shanghai, China), a JV between Shanghai Fosun Pharmaceutical Group Co. Ltd. (Shanghai:600196; HKSE:2196) and Henlius